Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Neurology
Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
ABT-089, an investigational drug for the treatment of mild to moderate Alzheimer's Disease
Phase II - ACC-001 Vaccine treatment for mild to moderate Alzheimer's Disease, trial study
Phase III - Avandia treatment for Alzheimer's disease as a means to reduce inflammation and increase sugar uptake in the brain.
Phase IV - Alzheimer's Disease Once-a-day Patch Medication, Trial Study
Alzheimer's Disease Clinical Research Study
Alzheimer's Disease Clinical Research Study
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer?s Disease Study CENA713DUS44
Mild to Moderate Alzheimer's disease
Mild to Moderate Alzheimer's disease
Alzheimer?s Disease Study CENA713DUS44
Study of an investigational medication for the treatment of Alzheimer's Disease
ALZHEIMER’S DISEASE RESEARCH STUDY
Alzheimer’s Disease Research Study Opportunity Currently Available
Alzheimer’s Research Study
For people with Alzheimer's there's no time to lose.
Global early-stage research study to evaluate an investigational medication for early-stage Alzheimer’s disease
Please take note of our Alzheimer's disease clinical research study.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Alzheimer's Disease Study
Bay Area Research Institute is conducting a clinical research trial of an investigational intravenous medication for mild to moderate Alzheimer’s disease in people between 50 and 88 years of age.
Bay Area Research Institute is conducting a clinical research trial of an investigational study medication in improving learning and memory in people with Alzheimer’s Disease.
Study of an investigational medication for the treatment of Alzheimer's Disease
Alzheimer's Disease - Memory Loss
Alzheimer's Disease - Memory Loss
Study of an investigational medication for the treatment of Alzheimer's Disease
Alzheimer's Research Study in Ventura County
Alzheimer's Research using Anti-Amyloid Beta Antibody in Ventura County
Cholesterol lowering agents to slow progression of Alzheimer's disease (CLASP study)
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Study of an investigational medication for the treatment of Alzheimer's Disease
Alzheimer’s Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Alzheimers? Be a Part of Research.
JOIN THE FIGHT AGAINST ALZHEIMER’S DISEASE
Research study of a currently marketed medication for Alzheimer’s Disease.
Research study of an investigational medication for those who are at risk to develop Alzheimer’s Disease.
Alzheimer?s Disease Study CENA713DUS44
Evaluation of a investigational oral medication for patients with Alzheimer’s Disease.
New Investigational Medication for Alzheimer’s disease
New treatment aimed at slowing down the progression of Alzheimer’s disease
Alzheimer’s Disease
Alzheimer’s? Questions about treatment options?
Alzheimer's Disease Research
Do you know or care for someone currently taking Aricept® for alzheimer's?
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
If you or someone you know is experiencing memory loss, they may qualify for a clinical research study currently being conducted by Radiant Research.
Research for Alzheimer's Disease
Alzheimer?s Disease Study CENA713DUS44
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Disease Clinical Study
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Clinical trial to assess the safety and tolerability of multiple oral doses of an investigational drug in elderly subjects with mild or moderate Alzheimer's disease on a stable dose of 10mg of Aricept daily.
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's study.
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Alzheimer's Disease
Alzheimer's study
St. Petersburg, FL - Alzheimer''s Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer?s Disease Study CENA713DUS44
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Do you have a loved one with Alzheimer's Disease?
Do you have mild to moderate Alzeimer's Disease?
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer?s Disease Study CENA713DUS44
Alzheimer's Disease Research
Alzheimer?s Disease Study CENA713DUS44
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer?s Disease Study CENA713DUS44
Alzheimer?s Disease Study CENA713DUS44
Phase 3 trial evaluating Treatment with intravenous Bapineuzumab vs. Placebo for Alzheimer's disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Randomized, Double blind, placebo controlled, parallel group, efficacy and safety trial of bapineuzumab in patients with mild to moderate Alzheimer's disease
Alzheimer's Fades Memories
To explore new ways of slowing the disease progression, we need your help.
Alzheimer?s Disease Study CENA713DUS44
Alzheimer?s Disease Study CENA713DUS44
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
A Multicenter, Randomized, Double-Blind, Placebo-Controlled
Study of the Safety, Tolerability, Pharmocodynamic and Pharmacokinetic
Effects of BMS-708163 in the Treatment of Patients With Prodromal
Alzheimer's Disease
CONCERT: A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Twelve-Month Safety and Efficacy Study Evaluating Dimebon in Patients with Mild-to-Moderate Alzheimer’s Disease on Donepezil
Alzheimer?s Disease Study CENA713DUS44
Are you facing Alzheimer’s?
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A study to determine the effectiveness of an investigational medication in the treatment of Alzheimer's Disease.
Alzheimer?s Disease Study CENA713DUS44
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab in Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E e4 Carriers
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Non- Carriers
Effect of LY450139 a y-Secretase Inhibitor, on the Progression of Alzheimer's Disease as Compared With Placebo
Effect of Passive Immunization on the Progression of Alzheimer's Disease: LY2062430 Versus Placebo
Alzheimer?s Disease Study CENA713DUS44
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer?s Disease Study CENA713DUS44
Are you or someone you know between the ages of 50 and 89 years of age with a diagnosis of mild to moderate Alzheimer's Disease?
Alzheimer?s Disease Study CENA713DUS44
Alzheimer?s Disease Study CENA713DUS44
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
Alzheimer's disease study for mild to moderate AD.
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer?s Disease Study CENA713DUS44
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer?s Disease Study CENA713DUS44
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Parker Jewish Institute for Health Care & Rehabilitation Seeks Study Volunteers with Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer?s Disease Study CENA713DUS44
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Do you or someone you care for have Alzheimer's Disease?
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Have you or someone you love been diagnosed with Alzheimer’s Disease?
Is Alzheimer’s Disease affecting your loved one?
Alzheimer?s Disease Study CENA713DUS44
ALZHEIMER'S DISEASE: Don't let those memories fade…
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Disease
Alzheimer?s Disease Study CENA713DUS44
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer's Research Study for People taking Aricept.
Memory Loss Research Study
Research Study for Agitation and Aggression Associated with Alzheimer’s Disease
Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease
ALZHEIMER’S DISEASE
BEHAVIOR & PERSONALITY CHANGES IN ALZHEIMER’S DISEASE
SUFFERING FROM ALZHEIMER’S DISEASE?
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Alzheimer?s Disease Study CENA713DUS44
The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility
Alzheimer?s Disease Study CENA713DUS44
Alzheimer?s Disease Study CENA713DUS44
Alzheimer’s Research Study
Alzheimer's Disease Research
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Have you or someone you love been diagnosed with Alzheimer's Disease?
Moderate to Severe Alzheimer’s
Alzheimer?s Disease Study CENA713DUS44
A clinical research trial evaluating an investigational drug for people with Alzheimer’s.
Alzheimer?s Disease Study CENA713DUS44
Alzheimer?s Disease Study CENA713DUS44
Alzheimer?s Disease Study CENA713DUS44
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Single Dose Study of R1450 in Patients With Alzheimer Disease.
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Single Dose Study of R1450 in Patients With Alzheimer Disease.
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Single Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.
A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease
A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.